Global CDMO PCI Pharma Services has earned a US Supply Chain Excellence Award.
The company was awarded this for its digital solution, which aims to streamline the management of clinical trials and the commercial lifespan of a drug post-launch.
PCI has been embarking on a five-year digital transformation journey to achieve elevated customer service through technological innovation, modernisation and security.
The award was bestowed by logistics-focused publishing company Akabo Media at a ceremony in mid-October. Nominees were judged based on criteria including business benefits, collaborative elements, innovation and overall project execution.
Among the distinguishing elements of pci | bridge is its collaborative-from-conception design.
PCI worked in close concert with four prominent customers to identify key pain points and corresponding solves, resulting in a solution that enhances supply chain visibility, while also reducing the time devoted to historically manual activities such as
- Forecasting
- Inventory management
- Simple reporting
- Supplier management
- Document sharing
- Distribution visibility
According to the company, pci | bridge aggregates real-time information across three pivotal operational domains – inventory, production, and distribution – providing up-to-date data access.
The ability to generate real-time reports concerning these three critical operations allows the platform to cater to the diverse, varying data analysis requirements throughout a drug product’s clinical trial period and commercial lifespan.
While many clinical trial management platforms deal exclusively with inventory management, the expanded scope inherent in pci | bridge allows the CDMO’s customers to utilize the solution straight through a product’s commercial launch – and beyond.
Chief Digital and Technology Officer for PCI Pharma Services, Wayne Hull, commented: “PCI has the privilege of partnering with pharmaceutical companies eager to embrace digital transformation in critical areas, including drug development processes, manufacturing
operations and patient care."
"With pci | bridge, we’ve collaborated with customers to bring the same automation-centric efficiencies and transparency to clinical trials and commercial launches. We’re exceptionally proud of our ever-evolving platform, and are grateful for its recognition as a next-generation pharma supply chain solution.”
Since the initial launch of pci | bridge, PCI has evolved the platform with a steady cadence of feature releases to improve user experience.
Often based on direct user feedback, these updates have spanned the platform’s purview from inventory and distribution to production
aspects such as scheduling, project oversight and document management.
